Stock Movers: Celsius, SoundHound, MetLife

Celsius shares tumbled after Q2 revenue rose 11% to $817.9M but missed the $872.6M consensus; Celsius line sales fell 12% due to competition. SoundHound shares surged on better-than-expected Q2 revenue, with D.A. Davidson noting results were well ahead of expectations. MetLife climbed as Q2 adjusted EPS rose ~20% to $2.43, beating the $2.30 estimate, helped by strong underwriting and 18% higher net investment income to $6.7B.

Analysis

CELH looks like a share-take story more than a demand-collapse story, which matters for positioning. The first-order hit is margin leverage: when the core brand loses velocity, promo intensity tends to rise and distribution partners become less patient, so the earnings downside can outpace the revenue miss over the next 1-2 quarters. Second-order, weaker CELH shelf productivity could benefit Monster and other functional-beverage peers by freeing up display space and retailer attention, but the trade is not automatic because retailers will test substitution before reallocating permanently.

MET is the cleaner fundamental compounder here because the beat likely reflects both underwriting discipline and a favorable investment-income backdrop. That is a slower-moving catalyst than a quarter-to-quarter EPS print: if rates stay elevated, the earnings power can re-rate over 6-12 months, while a rates drawdown would compress the story quickly. For SOUN, the market will likely extrapolate the upside beat, but this remains a high-multiple name where the burden is on sustained revenue surprise and not just one good quarter.

The contrarian take is that CELH may be oversold if this is mostly channel share rotation rather than permanent consumer defection; a stabilizing read-through from scanner data could trigger a sharp relief rally in 4-8 weeks. Conversely, SOUN’s move could be overdone if the beat is not accompanied by upward full-year guidance and clearer conversion to durable free cash flow. The key falsifiers are CELH weekly scanner trends and MET’s next rate-sensitive investment-income update; if CELH regains velocity or MET guidance implies falling reinvestment yields, the current positioning should be faded.

Key Decisions for Investors

• Short CELH on any relief bounce over the next 3-10 trading days; thesis is that core-brand share loss will pressure gross margin and force heavier promotion into Q3. Risk control: cover if scanner data shows sequential improvement or if management explicitly quantifies regained shelf space.
• Pair long MET / short a rate-sensitive financials basket or XLF over 1-3 months; MET has cleaner earnings visibility from underwriting plus investment income, while the short leg is meant to isolate the rate-spread and execution premium. Falsify if the next commentary implies net investment income is peaking.
• Trade SOUN tactically, not structurally: long only on follow-through above the post-earnings gap for a 1-4 week momentum window, with a tight stop if the stock gives back the initial gap. The risk/reward is asymmetric only if guidance revisions confirm the beat was not one-off.